1 completed, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Systemic Mastocytosis: new trials by email Literature Review of Systemic Mastocytosis trials Research Report on Systemic Mastocytosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis Denosumab, Placebo - Osteoporosis, Systemic Mastocytosis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 24 | 2018-03-05 | 2026-03-31 |
| Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis Cladribine and pegylated interpheron alpha-2a - Systemic Mastocytosis | Phase 2 / Phase 3 | Unknown | Hospital Virgen de la Salud | 10 | 2012-05-01 | 2016-08-29 |
Mastocytosis, Systemic (2) · Mast Cell Activation Disorders (1) · Mastocytosis (1) · Osteoporosis (1)
Immune System Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Mast Cell Activation Disorders (1) · Mastocytosis (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1)
Cladribine (1) · Denosumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Hospital Virgen de la Salud (1)
France (1) · Spain (1)
Luis Escribano, MD, PhD (1) · Olivier Hermine, MD (1)
2016 (1)